/ 2015
Photo credit: Ardalan Ranjbari

The Plant


SD1

 Rightfully, we look at our production of biopharmaceuticals as one of the most serious production lines known for human well-being. CinnaGen plant is built up in 4 levels in 4000 m² area. The facility consists of different sections for molecular biology, QC labs, mammalian cell culture, E.coli fermentation, purification, monoclonal antibody production, synthetic peptide chemistry labs, quality assurance offices as well as administration departments. Our 800 m²clean rooms designed for production of recombinant protein expressed in mammalian cell line (CHO), monoclonal antibodies and recombinant therapeutic proteins expressed in E.coli are in complete compliance with cGMP rules and regulations. Our products are manufactured in premises that meet all the environmental regulations for this industry. The facility design, materials, finishing and flows meet all the quality criteria for manufacturing biological products

 

SD2

 A new production site opened on the last quarter of 2012.The plant is constructed in compliance with EU standards in biopharmaceuticals production and is expected to increase current production capacity significantly. This new site is built in three levels and covers more than 6000( m2 )that include 4500( m2)clean-room area and space for technical maintenance and engine room on a technical floor.

SD3

This new facility (SD3) was built on march 2013 which consist of 350 m2 conference hall which also is considered as a canteen, 1150 m2 warehouse dedicated for packaging and raw materials and 250 m2 as technical and maintenance which supports the whole facility.

 

SD4

This new cGMP production plant (SD4) was opened on the last quarter of 2016 which was designed in three different floors. 1200 m2 is dedicated for production of monoclonal antibodies. This area consists of upstream and downstream processes that contains two 4500 lit bioreactors for mammalian cell culture.

Also we are equipped with a cartridge filling line which enables us to produce our drug products as pen.  This area including the packaging department is 1200 m2.

A Total area of 2400 m2 technical and maintenance is considered to support the whole production facility.

Jan2016 / Public Relations Department / CinnaGen